Objectives: Amyloid beta 1-42 (Aβ 1-42) is related to several disorders including nervous, cardiovascular and metabolic disorder. We investigated plasma Aβ 1-42 level and examined its correlation with some cardiovascular risk factors.
Trang 1INVESTIGATION OF PLASMA AMYLOID BETA 1-42 LEVELS
AND ITS CORRELATION WITH SOME CARDIOVASCULAR RISK FACTORS IN PEOPLE OVER FORTY YEARS OLD
Nguyen Minh Hai*; Nguyen Minh Nui*; Ho Anh Son**
SUMMARY
Objectives: Amyloid beta 1-42 (Aβ 1-42) is related to several disorders including nervous, cardiovascular and metabolic disorder We investigated plasma Aβ 1-42 level and examined its correlation with some cardiovascular risk factors Subjects and methods: Level of Aβ 1-42 was measured in plasma of 40 people over forty years old without type 2 diabetes mellitus and hypertension by ELISA method Results and conclusions: Average plasma Aβ 1-42 level was 98.88 ± 92.45 pg/mL, median was 65.49 pg/mL with wide range from 45.83 to 494.32 pg/mL There was no significant correlation between plasma Aβ 1-42 level and cardiovascular risk factors such as age, plasma lipids
* Key words: Metabolic disorder; Amyloid beta
INTRODUCTION
Amyloid is a specific peptide family
including aggregating beta chains Small,
focal, clinically silent amyloid deposits in
the brain, heart, seminal vesicles, and joints
is a universal accompaniment of aging
These results in amyloidosis, structural
disorders, reduction and loss in function of
various organs in the body The underlying
molecular abnormalities may be either
acquired or hereditary and about 20 different
proteins can form clinically or pathologically
significant amyloid fibrils in vivo Brain
amyloid deposit is a major pathological
feature of Alzheimer disease Islet amyloid
deposits trigger type 2 diabetes mellitus
Amyloid also deposits in joints, peripheral
arteries, kidneys Aβ 1-42 is one of amyloid
molecular, which is considered to relate
with different diseases such as Alzheimer’s
disease, diabetes, cardiovascular diseases [2] Although many studies about Aβ 1-42 have been performed, its role and physical function is still unknown So far in Vietnam, there has been no investigation about the exact physical function of Aβ 1-42 Therefore, we carry out this study to:
- Examine the level of Aβ 1-42 plasma
in the people over 40 years old
- Investigate whether there is any relationship between plasma Aβ 1-42 level and cardiovascular risk factors
SUBJECTS AND METHODS
1 Subjects
* Selection criteria:
Study was carried out on 40 people over forty years old without type 2 diabetes
mellitus and hypertension
* 103 Hospital
** Military Medical University
Corresponding author: Nguyen Minh Nui (minhnuinguyen@gmail.com)
Trang 22 Methods
- Cross-sectional study without control
group
- All people were clinically and paraclinically
examined by measuring weight, height,
blood pressure, level of glucose, creatinine,
acid uric, lipid in their blood Level of
Aβ 1-42 plasma was measured by ELISA
method in Physiopathology Department,
Vietnam Millitary Medical University
- Methods of Aβ 1-42 measurement [9]:
+ 5 mL of whole bood was taken into
tubes with anticoagulant (citrate) in the
morning Afterward, the sample was
centrifugated for 20 min at 2,000 rpm
Collect the supernatant carefully as plasma
sample If precipitate was seen during
reservation, the sample should be centrifugated
again
+ The Microelisa stripplate provided in
the ELISA kit has been pre-coated with an
antibody specific to Aβ 1-42 Standards or
samples were added to the appropriate
Microelisa stripplate wells and combined
to the specific antibody Then a Horseradish
Peroxidase (HRP) - conjugated antibody
specific for Aβ 1-42 was added to each
Microelisa stripplate well and incubated
Free components were washed away before
adding the Chromogen solution A and
Chromogen solution B to each well Blue
only appreared in those wells that contain
Aβ 1-42 and Horseradish peroxidase
conjugated Aβ 1-42 antibody and then it
turned yellow after addition of the stop
solution The optical density is measured
spectrophotometrically at a wavelength
of 450 nm The optical density value is
proportional to the concentration of Aβ 1-42 The concentration of Aβ 1-42 in the samples is calculated by comparing the optical density of the samples to the standard curve
* Statistical analysis: to initially explore the relationship between variable sets, scattergram blots using Microsoft Excell (2010), where a relationship was found Stata verson 12.0 was used to verify the statistical significances of the association Simple linear regression was initially used Pearson chi-square was used to determine the association between concentration
of Aβ 1-42 plasma and baseline participant characteristics
RESULTS
1 Characteristics of the subjects
40 people included 24 males (60%) and
16 females (40%) Mean age was 54.38 ±
11.23 years
2 Plasma Aβ 1-42 levels
Table 1: Plasma Aβ 1-42 level
Variable
Level of Aβ 1-42 plasma
(pg/ml)
Mean ± SD Median
(Min - max) Male (n = 24) 83.77 ± 58.17 64.46
(45.83 - 313.64) Female (n = 16) 121.55 ± 126.97 66.67
(47.59 - 494.32) Summarization 98.88 ± 92.45 65.49
(45.83 - 494.32)
Both mean and medium plasma Aβ 1-42
in male were not significantly lower than those in female (p > 0.05) Levels of Aβ 1-42 fluctuated from 45.83 pg/mL to 494.32 pg/mL
Trang 33 Association between plasma Aβ 1-42 levels with age, blood glucose and
acid uric levels
* Association between plasma Aβ 1-42 levels and age:
Figure 1: Correlation between plasma Aβ 1-42 levels and age
No significant correlation between plasma Aβ 1-42 levels and age of participants was
found (p > 0.05)
* Association of plasma Aβ 1-42 level with blood glucose and acid uric levels:
A = 5.6765 * Glucose + 71.579
r = 0.043, p= 0.79
0
100
200
300
400
500
600
Glucose (mmol/L)
A = -0.311 * Uric + 209.48
r = 0.251, p = 0.11
0 100 200 300 400 500 600
Acid uric (µmol/L)
A B
Figure 2: Correlation between plasma Aβ 1-42 levels and glucose (A),
acid uric (B) levels
Plasma Aβ 1-42 levels did not correlate with either glucose or acid uric levels (p > 0.05)
Trang 44 Association between plasma Aβ 1-42 levels with total cholesterol, HDL-C, LDL-C, and triglyceride levels
A = -20.324 * Cholesterol + 208.69
r = -0.022, p = 0.61
0
100
200
300
400
500
600
Cholesterol (mmol/L)
A = -7.332 * Triglyceride +114.19
r = -0.138, p = 0.43
0 100 200 300 400 500 600
Triglyceride (mmol/L)
A B
A= 111.17 * HDL - 40.721
r = 0.327, p = 0.08
0
100
200
300
400
500
600
HDL-C (mmol/L)
A = -37.177 * LDL + 222.65
r =-0.34, p = 0.44
0 100 200 300 400 500 600
LDL-C (mmol/L)
C D
Figure 1: Correlation between plasma Aβ 1-42 levels, cholesterol (A), triglyceride (B),
HDL-C (C) and LDL-C (D)
No significant correlation of plasma Aβ 1-42 plasma levels with cholesterol, triglyceride, HDL-C and LDL-C was observed
DISCUSSION
Aβ 1-42 is supposed to relate to a variety
of disorders such as Alzheimer’s disease,
type 2 diabetes mellitus In the body, Aβ 1-42
can be solute in cerebrospinal fluid and blood or deposits in brain, pancreas
We investigated whether there were any associations between plasma Aβ 1-42 levels and cardiovascular risk factors
Trang 5In our study, the mean (±SD) and median
plasma Aβ 1-42 were 98.88 ± 92.45 (pg/mL)
and 65.49 (pg/mL) The concentration of
Aβ 1-42 plasma fluctuated in a large range
between 45.83 (pg/mL) and approximately
500 (pg/mL) It was interesting to note that
participants who had the highest plasma
Aβ 1-42 level had normal levels of lipid,
glucose, acid uric in the blood with total
cholesterol = 5.17 (mmol/L), HDL-C = 1.8
mmol/L, LDL-C = 3 (mmol/L), LDL-C = 3
(mmol/L), triglyceride = 0.54 (mmol/L), acid
uric = 327 (µmol/L)
In the study by Kelvin et al, mean (±SD)
and medium of plasma Aβ 1-42 levels in
a group of 18 healthy adults were 29.1 ±
18.1 (pg/mL) and 27 (pg/mL) These results
were lower than our findings and the
concentration of plasma Aβ 1-42 levels
fluctuated in narrower range between 2.5
(pg/mL) and 62 (pg/mL) However, mean
age of the participants in Kelvin’s research
was 36, which was lower than the figure
in our study [4]
In 2000, Mehta and his colleagues
conducted a study on the patients older
than forty with Alzheimer’s disease and
control subjects Levels of Aβ 1-42 plasma
were measured by a sandwich
enzyme-linked immunosorbent assay Both the
medium of plasma Aβ 1-42 levels in group
of Alzheimer’s disease and control group
were higher than the results of our study
with 73 (pg/mL) (minimum = 25 pg/mL,
maximum = 880 pg/mL) and 81 (pg/mL)
(minimum = 25 pg/mL, maximum = 905
pg/mL), respectively The plasma Aβ 1-42
levels also fluctuated in a large range [6]
Metti and his colleagues (2012) used Innogenetics INNO-BIA assays to measure plasma Aβ 1-42 level in 988 community-dwelling elders who suffer from diabetes, stroke, myocardial infarction and hypertension Mean age of these patients was 74.0 ±
3 years The mean (±SD) and median of plasma Aβ 1-42 levels were 33.9 ± 9.7 and 32.83 (pg/mL) [7] The mean and plasma
Aβ 1-42 levels in our study were both similar
to Mehta and Metti’s findings Thus, the differences in plasma Aβ 1-42 levels in these studies were affected significantly
by age
High plasma cholesterol, triglyceride and LDL levels, as well as low plasma HDL levels have long been known to be associated with cardiovascular risk factors and have been identified as significant risk factors for Alzheimer’s disease HDL has been shown to carry Aβ 1-42 in plasma and cerebrospinal fluid [1] Plasma HDL has been reported to be lower in patients with Alzheimer’s disease and is highly correlated with lower cognitive scores from these patients [1, 3] Many studies indicated that HDL which interact with
Aβ 1-42 in plasma, can regulate Aβ 1-42 aggregation, degradation and toxicity [5, 8] Our study did not show significant associations between levels of total cholesterol, triglyceride, LDL-C or HDL-C and Aβ 1-42 levels This results were similar to those of Kelvin et al in 2005 [4] However, our study was performed in healthy individuals Whether there is any correlation between Aβ 1-42 levels and cardiovascular risk factors in diabetic patients
as well as in healthy people, which need
to be investigated in the future
Trang 6CONCLUSION
The mean and medium of plasma Aβ 1-42
levels in people over forty years old were
98.88 ± 92.45 (pg/mL) and 65.49 (pg/mL)
and plasma Aβ 1-42 levels fluctuated in a
large range between 45.83 (pg/mL) and
494.32 (pg/mL) No correlations between
Aβ 1-42 levels and several cardiovascular
risk factors such age, plasma glucose,
acid uric and lipids levels were observed
REFERENCES
1 Cole G M, Beech W, Frautschy S A et al.
Lipoprotein effects on Abeta accumulation and
degradation by microglia in vitro J Neurosci Res
1999, 57 (4), pp 504-520
2 David A Warrell, Timothy M Cox, Firth
Oxford University Press 2003, pp.163-167
density lipoprotein decreases beta-amyloid
toxicity in cortical cell culture Neuroreport
1997, 8 (5), pp.1127-1130
4 Kelvin Balakrishnana, Giuseppe Verdilea,
positively with increased body fat in healthy individuals Journal of Alzheimer’s Disease
2005, 8, pp.269-282
5 Kuo YM, Emmerling MR, Bisgaier CL et al
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels Biochem Biophys Res Commun 1998, 252 (3), pp.711-715
6 Mehta PD, Pirttila T, Mehta SP et al.
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease Arch Neurol 2000, 57 (1),
pp 5-100
7 Metti AL, Cauley JA, Newman AB et al.
Plasma beta amyloid level and depression in older adults J Gerontol A Biol Sci Med Sci
2013, 68 (1), pp.74-79
lipoprotein inhibits assembly of amyloid beta-peptides into fibrils Biochem Biophys Res Commun 2000, 270 (1), pp.62-66
9 Schmidt S, Matthew J, Nixon R, Mathews
immunosorbent assay in Sigurdsson, E.M., Calero, M & Gasset, M (eds.) Amyloid Proteins Methods in Molecular Biology: Humana Press 2012, pp.507-527